12:00 AM
 | 
Mar 20, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

5-HT3 receptor antagonists regulatory update

VVUS received U.S. Patent No. 6,037,360 covering the oral, topical, transdermal and...

Read the full 40 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >